 | • レポートコード：QY2207E10429 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,102,500 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界の核酸系遺伝子治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に核酸系遺伝子治療の世界市場のxxx％を占める「抗センス＆抗遺伝子」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院＆診療所」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の核酸系遺伝子治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの核酸系遺伝子治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの核酸系遺伝子治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 核酸系遺伝子治療のグローバル主要メーカーには、Wave Life Sciences、Imugene、Sarepta Therapeutics、Alnylam Pharmaceuticals、Ionis Pharmaceuticals、Moderna、BioNTech、Nutcracker Therapeutics、Deep Genomics、Sirnaomics、Laronde、Abogen Biosciencesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 核酸系遺伝子治療市場は、種類と用途によって区分されます。世界の核酸系遺伝子治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 抗センス＆抗遺伝子、短阻害配列、遺伝子導入療法、ヌクレオシド類似体、リボザイム、アプタマー、その他 【用途別セグメント】 病院＆診療所、学術＆研究機関、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 核酸系遺伝子治療製品概要 - 種類別市場（抗センス＆抗遺伝子、短阻害配列、遺伝子導入療法、ヌクレオシド類似体、リボザイム、アプタマー、その他） - 用途別市場（病院＆診療所、学術＆研究機関、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の核酸系遺伝子治療販売量予測2017-2028 - 世界の核酸系遺伝子治療売上予測2017-2028 - 核酸系遺伝子治療の地域別販売量 - 核酸系遺伝子治療の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別核酸系遺伝子治療販売量 - 主要メーカー別核酸系遺伝子治療売上 - 主要メーカー別核酸系遺伝子治療価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（抗センス＆抗遺伝子、短阻害配列、遺伝子導入療法、ヌクレオシド類似体、リボザイム、アプタマー、その他） - 核酸系遺伝子治療の種類別販売量 - 核酸系遺伝子治療の種類別売上 - 核酸系遺伝子治療の種類別価格 ・用途別市場規模（病院＆診療所、学術＆研究機関、その他） - 核酸系遺伝子治療の用途別販売量 - 核酸系遺伝子治療の用途別売上 - 核酸系遺伝子治療の用途別価格 ・北米市場 - 北米の核酸系遺伝子治療市場規模（種類別、用途別） - 主要国別の核酸系遺伝子治療市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの核酸系遺伝子治療市場規模（種類別、用途別） - 主要国別の核酸系遺伝子治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の核酸系遺伝子治療市場規模（種類別、用途別） - 主要国別の核酸系遺伝子治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の核酸系遺伝子治療市場規模（種類別、用途別） - 主要国別の核酸系遺伝子治療市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの核酸系遺伝子治療市場規模（種類別、用途別） - 主要国別の核酸系遺伝子治療市場規模（トルコ、サウジアラビア） ・企業情報 Wave Life Sciences、Imugene、Sarepta Therapeutics、Alnylam Pharmaceuticals、Ionis Pharmaceuticals、Moderna、BioNTech、Nutcracker Therapeutics、Deep Genomics、Sirnaomics、Laronde、Abogen Biosciences ・産業チェーン及び販売チャネル分析 - 核酸系遺伝子治療の産業チェーン分析 - 核酸系遺伝子治療の原材料 - 核酸系遺伝子治療の生産プロセス - 核酸系遺伝子治療の販売及びマーケティング - 核酸系遺伝子治療の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 核酸系遺伝子治療の産業動向 - 核酸系遺伝子治療のマーケットドライバー - 核酸系遺伝子治療の課題 - 核酸系遺伝子治療の阻害要因 ・主な調査結果 |
Gene therapy is used for correcting defective genes that are responsible for disease development. Moreover, nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there exists no permanent cure such as anaemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.
Market Analysis and Insights: Global Nucleic Acid Based Gene Therapy Market
The global Nucleic Acid Based Gene Therapy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Anti-Sence and Anti-Gene accounting for % of the Nucleic Acid Based Gene Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals and Clinics segment is altered to an % CAGR throughout this forecast period.
China Nucleic Acid Based Gene Therapy market size is valued at US$ million in 2021, while the North America and Europe Nucleic Acid Based Gene Therapy are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Nucleic Acid Based Gene Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nucleic Acid Based Gene Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nucleic Acid Based Gene Therapy market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nucleic Acid Based Gene Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nucleic Acid Based Gene Therapy market.
Global Nucleic Acid Based Gene Therapy Scope and Market Size
Nucleic Acid Based Gene Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Nucleic Acid Based Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Anti-Sence and Anti-Gene
Short Inhibitory Sequences
Gene Transfer Therapy
Nucleoside Analogs
Ribozymes
Aptamers
Others
Segment by Application
Hospitals and Clinics
Academic and Research Institutes
Others
By Company
Wave Life Sciences
Imugene
Sarepta Therapeutics
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Moderna
BioNTech
Nutcracker Therapeutics
Deep Genomics
Sirnaomics
Laronde
Abogen Biosciences
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Based Gene Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Anti-Sence and Anti-Gene
1.2.3 Short Inhibitory Sequences
1.2.4 Gene Transfer Therapy
1.2.5 Nucleoside Analogs
1.2.6 Ribozymes
1.2.7 Aptamers
1.2.8 Others
1.3 Market by Application
1.3.1 Global Nucleic Acid Based Gene Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Academic and Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Based Gene Therapy Market Perspective (2017-2028)
2.2 Nucleic Acid Based Gene Therapy Growth Trends by Region
2.2.1 Nucleic Acid Based Gene Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nucleic Acid Based Gene Therapy Historic Market Size by Region (2017-2022)
2.2.3 Nucleic Acid Based Gene Therapy Forecasted Market Size by Region (2023-2028)
2.3 Nucleic Acid Based Gene Therapy Market Dynamics
2.3.1 Nucleic Acid Based Gene Therapy Industry Trends
2.3.2 Nucleic Acid Based Gene Therapy Market Drivers
2.3.3 Nucleic Acid Based Gene Therapy Market Challenges
2.3.4 Nucleic Acid Based Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid Based Gene Therapy Players by Revenue
3.1.1 Global Top Nucleic Acid Based Gene Therapy Players by Revenue (2017-2022)
3.1.2 Global Nucleic Acid Based Gene Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Nucleic Acid Based Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nucleic Acid Based Gene Therapy Revenue
3.4 Global Nucleic Acid Based Gene Therapy Market Concentration Ratio
3.4.1 Global Nucleic Acid Based Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Based Gene Therapy Revenue in 2021
3.5 Nucleic Acid Based Gene Therapy Key Players Head office and Area Served
3.6 Key Players Nucleic Acid Based Gene Therapy Product Solution and Service
3.7 Date of Enter into Nucleic Acid Based Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Based Gene Therapy Breakdown Data by Type
4.1 Global Nucleic Acid Based Gene Therapy Historic Market Size by Type (2017-2022)
4.2 Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Type (2023-2028)
5 Nucleic Acid Based Gene Therapy Breakdown Data by Application
5.1 Global Nucleic Acid Based Gene Therapy Historic Market Size by Application (2017-2022)
5.2 Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nucleic Acid Based Gene Therapy Market Size (2017-2028)
6.2 North America Nucleic Acid Based Gene Therapy Market Size by Type
6.2.1 North America Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022)
6.2.2 North America Nucleic Acid Based Gene Therapy Market Size by Type (2023-2028)
6.2.3 North America Nucleic Acid Based Gene Therapy Market Share by Type (2017-2028)
6.3 North America Nucleic Acid Based Gene Therapy Market Size by Application
6.3.1 North America Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022)
6.3.2 North America Nucleic Acid Based Gene Therapy Market Size by Application (2023-2028)
6.3.3 North America Nucleic Acid Based Gene Therapy Market Share by Application (2017-2028)
6.4 North America Nucleic Acid Based Gene Therapy Market Size by Country
6.4.1 North America Nucleic Acid Based Gene Therapy Market Size by Country (2017-2022)
6.4.2 North America Nucleic Acid Based Gene Therapy Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Nucleic Acid Based Gene Therapy Market Size (2017-2028)
7.2 Europe Nucleic Acid Based Gene Therapy Market Size by Type
7.2.1 Europe Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022)
7.2.2 Europe Nucleic Acid Based Gene Therapy Market Size by Type (2023-2028)
7.2.3 Europe Nucleic Acid Based Gene Therapy Market Share by Type (2017-2028)
7.3 Europe Nucleic Acid Based Gene Therapy Market Size by Application
7.3.1 Europe Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022)
7.3.2 Europe Nucleic Acid Based Gene Therapy Market Size by Application (2023-2028)
7.3.3 Europe Nucleic Acid Based Gene Therapy Market Share by Application (2017-2028)
7.4 Europe Nucleic Acid Based Gene Therapy Market Size by Country
7.4.1 Europe Nucleic Acid Based Gene Therapy Market Size by Country (2017-2022)
7.4.2 Europe Nucleic Acid Based Gene Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size (2017-2028)
8.2 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Type
8.2.1 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Nucleic Acid Based Gene Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Application
8.3.1 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Nucleic Acid Based Gene Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Region
8.4.1 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nucleic Acid Based Gene Therapy Market Size (2017-2028)
9.2 Latin America Nucleic Acid Based Gene Therapy Market Size by Type
9.2.1 Latin America Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Nucleic Acid Based Gene Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Nucleic Acid Based Gene Therapy Market Share by Type (2017-2028)
9.3 Latin America Nucleic Acid Based Gene Therapy Market Size by Application
9.3.1 Latin America Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Nucleic Acid Based Gene Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Nucleic Acid Based Gene Therapy Market Share by Application (2017-2028)
9.4 Latin America Nucleic Acid Based Gene Therapy Market Size by Country
9.4.1 Latin America Nucleic Acid Based Gene Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Nucleic Acid Based Gene Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size (2017-2028)
10.2 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Type
10.2.1 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Nucleic Acid Based Gene Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Application
10.3.1 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Nucleic Acid Based Gene Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Country
10.4.1 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Wave Life Sciences
11.1.1 Wave Life Sciences Company Details
11.1.2 Wave Life Sciences Business Overview
11.1.3 Wave Life Sciences Nucleic Acid Based Gene Therapy Introduction
11.1.4 Wave Life Sciences Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.1.5 Wave Life Sciences Recent Developments
11.2 Imugene
11.2.1 Imugene Company Details
11.2.2 Imugene Business Overview
11.2.3 Imugene Nucleic Acid Based Gene Therapy Introduction
11.2.4 Imugene Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.2.5 Imugene Recent Developments
11.3 Sarepta Therapeutics
11.3.1 Sarepta Therapeutics Company Details
11.3.2 Sarepta Therapeutics Business Overview
11.3.3 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Introduction
11.3.4 Sarepta Therapeutics Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.3.5 Sarepta Therapeutics Recent Developments
11.4 Alnylam Pharmaceuticals
11.4.1 Alnylam Pharmaceuticals Company Details
11.4.2 Alnylam Pharmaceuticals Business Overview
11.4.3 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Introduction
11.4.4 Alnylam Pharmaceuticals Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.4.5 Alnylam Pharmaceuticals Recent Developments
11.5 Ionis Pharmaceuticals
11.5.1 Ionis Pharmaceuticals Company Details
11.5.2 Ionis Pharmaceuticals Business Overview
11.5.3 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Introduction
11.5.4 Ionis Pharmaceuticals Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.5.5 Ionis Pharmaceuticals Recent Developments
11.6 Moderna
11.6.1 Moderna Company Details
11.6.2 Moderna Business Overview
11.6.3 Moderna Nucleic Acid Based Gene Therapy Introduction
11.6.4 Moderna Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.6.5 Moderna Recent Developments
11.7 BioNTech
11.7.1 BioNTech Company Details
11.7.2 BioNTech Business Overview
11.7.3 BioNTech Nucleic Acid Based Gene Therapy Introduction
11.7.4 BioNTech Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.7.5 BioNTech Recent Developments
11.8 Nutcracker Therapeutics
11.8.1 Nutcracker Therapeutics Company Details
11.8.2 Nutcracker Therapeutics Business Overview
11.8.3 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Introduction
11.8.4 Nutcracker Therapeutics Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.8.5 Nutcracker Therapeutics Recent Developments
11.9 Deep Genomics
11.9.1 Deep Genomics Company Details
11.9.2 Deep Genomics Business Overview
11.9.3 Deep Genomics Nucleic Acid Based Gene Therapy Introduction
11.9.4 Deep Genomics Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.9.5 Deep Genomics Recent Developments
11.10 Sirnaomics
11.10.1 Sirnaomics Company Details
11.10.2 Sirnaomics Business Overview
11.10.3 Sirnaomics Nucleic Acid Based Gene Therapy Introduction
11.10.4 Sirnaomics Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.10.5 Sirnaomics Recent Developments
11.11 Laronde
11.11.1 Laronde Company Details
11.11.2 Laronde Business Overview
11.11.3 Laronde Nucleic Acid Based Gene Therapy Introduction
11.11.4 Laronde Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.11.5 Laronde Recent Developments
11.12 Abogen Biosciences
11.12.1 Abogen Biosciences Company Details
11.12.2 Abogen Biosciences Business Overview
11.12.3 Abogen Biosciences Nucleic Acid Based Gene Therapy Introduction
11.12.4 Abogen Biosciences Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022)
11.12.5 Abogen Biosciences Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Nucleic Acid Based Gene Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Anti-Sence and Anti-Gene
Table 3. Key Players of Short Inhibitory Sequences
Table 4. Key Players of Gene Transfer Therapy
Table 5. Key Players of Nucleoside Analogs
Table 6. Key Players of Ribozymes
Table 7. Key Players of Aptamers
Table 8. Key Players of Others
Table 9. Global Nucleic Acid Based Gene Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Nucleic Acid Based Gene Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Nucleic Acid Based Gene Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Nucleic Acid Based Gene Therapy Market Share by Region (2017-2022)
Table 13. Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Nucleic Acid Based Gene Therapy Market Share by Region (2023-2028)
Table 15. Nucleic Acid Based Gene Therapy Market Trends
Table 16. Nucleic Acid Based Gene Therapy Market Drivers
Table 17. Nucleic Acid Based Gene Therapy Market Challenges
Table 18. Nucleic Acid Based Gene Therapy Market Restraints
Table 19. Global Nucleic Acid Based Gene Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Nucleic Acid Based Gene Therapy Revenue Share by Players (2017-2022)
Table 21. Global Top Nucleic Acid Based Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Based Gene Therapy as of 2021)
Table 22. Ranking of Global Top Nucleic Acid Based Gene Therapy Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Nucleic Acid Based Gene Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Nucleic Acid Based Gene Therapy Product Solution and Service
Table 26. Date of Enter into Nucleic Acid Based Gene Therapy Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Type (2017-2022)
Table 30. Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Type (2023-2028)
Table 32. Global Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Nucleic Acid Based Gene Therapy Revenue Share by Application (2017-2022)
Table 34. Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Nucleic Acid Based Gene Therapy Revenue Share by Application (2023-2028)
Table 36. North America Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 37. North America Nucleic Acid Based Gene Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 38. North America Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 39. North America Nucleic Acid Based Gene Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 40. North America Nucleic Acid Based Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 41. North America Nucleic Acid Based Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 42. Europe Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 43. Europe Nucleic Acid Based Gene Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 44. Europe Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 45. Europe Nucleic Acid Based Gene Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 46. Europe Nucleic Acid Based Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 47. Europe Nucleic Acid Based Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 48. Asia Pacific Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 49. Asia Pacific Nucleic Acid Based Gene Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 50. Asia Pacific Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 51. Asia Pacific Nucleic Acid Based Gene Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 52. Asia Pacific Nucleic Acid Based Gene Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 53. Asia Pacific Nucleic Acid Based Gene Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 54. Latin America Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 55. Latin America Nucleic Acid Based Gene Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 56. Latin America Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 57. Latin America Nucleic Acid Based Gene Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 58. Latin America Nucleic Acid Based Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 59. Latin America Nucleic Acid Based Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 66. Wave Life Sciences Company Details
Table 67. Wave Life Sciences Business Overview
Table 68. Wave Life Sciences Nucleic Acid Based Gene Therapy Product
Table 69. Wave Life Sciences Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022) & (US$ Million)
Table 70. Wave Life Sciences Recent Developments
Table 71. Imugene Company Details
Table 72. Imugene Business Overview
Table 73. Imugene Nucleic Acid Based Gene Therapy Product
Table 74. Imugene Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022) & (US$ Million)
Table 75. Imugene Recent Developments
Table 76. Sarepta Therapeutics Company Details
Table 77. Sarepta Therapeutics Business Overview
Table 78. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product
Table 79. Sarepta Therapeutics Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022) & (US$ Million)
Table 80. Sarepta Therapeutics Recent Developments
Table 81. Alnylam Pharmaceuticals Company Details
Table 82. Alnylam Pharmaceuticals Business Overview
Table 83. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product
Table 84. Alnylam Pharmaceuticals Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022) & (US$ Million)
Table 85. Alnylam Pharmaceuticals Recent Developments
Table 86. Ionis Pharmaceuticals Company Details
Table 87. Ionis Pharmaceuticals Business Overview
Table 88. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product
Table 89. Ionis Pharmaceuticals Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022) & (US$ Million)
Table 90. Ionis Pharmaceuticals Recent Developments
Table 91. Moderna Company Details
Table 92. Moderna Business Overview
Table 93. Moderna Nucleic Acid Based Gene Therapy Product
Table 94. Moderna Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022) & (US$ Million)
Table 95. Moderna Recent Developments
Table 96. BioNTech Company Details
Table 97. BioNTech Business Overview
Table 98. BioNTech Nucleic Acid Based Gene Therapy Product
Table 99. BioNTech Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022) & (US$ Million)
Table 100. BioNTech Recent Developments
Table 101. Nutcracker Therapeutics Company Details
Table 102. Nutcracker Therapeutics Business Overview
Table 103. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product
Table 104. Nutcracker Therapeutics Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022) & (US$ Million)
Table 105. Nutcracker Therapeutics Recent Developments
Table 106. Deep Genomics Company Details
Table 107. Deep Genomics Business Overview
Table 108. Deep Genomics Nucleic Acid Based Gene Therapy Product
Table 109. Deep Genomics Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022) & (US$ Million)
Table 110. Deep Genomics Recent Developments
Table 111. Sirnaomics Company Details
Table 112. Sirnaomics Business Overview
Table 113. Sirnaomics Nucleic Acid Based Gene Therapy Product
Table 114. Sirnaomics Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022) & (US$ Million)
Table 115. Sirnaomics Recent Developments
Table 116. Laronde Company Details
Table 117. Laronde Business Overview
Table 118. Laronde Nucleic Acid Based Gene Therapy Product
Table 119. Laronde Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022) & (US$ Million)
Table 120. Laronde Recent Developments
Table 121. Abogen Biosciences Company Details
Table 122. Abogen Biosciences Business Overview
Table 123. Abogen Biosciences Nucleic Acid Based Gene Therapy Product
Table 124. Abogen Biosciences Revenue in Nucleic Acid Based Gene Therapy Business (2017-2022) & (US$ Million)
Table 125. Abogen Biosciences Recent Developments
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nucleic Acid Based Gene Therapy Market Share by Type: 2021 VS 2028
Figure 2. Anti-Sence and Anti-Gene Features
Figure 3. Short Inhibitory Sequences Features
Figure 4. Gene Transfer Therapy Features
Figure 5. Nucleoside Analogs Features
Figure 6. Ribozymes Features
Figure 7. Aptamers Features
Figure 8. Others Features
Figure 9. Global Nucleic Acid Based Gene Therapy Market Share by Application: 2021 VS 2028
Figure 10. Hospitals and Clinics Case Studies
Figure 11. Academic and Research Institutes Case Studies
Figure 12. Others Case Studies
Figure 13. Nucleic Acid Based Gene Therapy Report Years Considered
Figure 14. Global Nucleic Acid Based Gene Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Nucleic Acid Based Gene Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Nucleic Acid Based Gene Therapy Market Share by Region: 2021 VS 2028
Figure 17. Global Nucleic Acid Based Gene Therapy Market Share by Players in 2021
Figure 18. Global Top Nucleic Acid Based Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Based Gene Therapy as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Nucleic Acid Based Gene Therapy Revenue in 2021
Figure 20. North America Nucleic Acid Based Gene Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 21. North America Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2017-2028)
Figure 22. North America Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2017-2028)
Figure 23. North America Nucleic Acid Based Gene Therapy Market Size Share by Country (2017-2028)
Figure 24. United States Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Nucleic Acid Based Gene Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 27. Europe Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2017-2028)
Figure 28. Europe Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2017-2028)
Figure 29. Europe Nucleic Acid Based Gene Therapy Market Size Share by Country (2017-2028)
Figure 30. Germany Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. France Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. U.K. Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Italy Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Russia Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Nordic Countries Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Nucleic Acid Based Gene Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 37. Asia Pacific Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2017-2028)
Figure 38. Asia Pacific Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2017-2028)
Figure 39. Asia Pacific Nucleic Acid Based Gene Therapy Market Size Share by Region (2017-2028)
Figure 40. China Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Japan Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. South Korea Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Southeast Asia Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. India Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Australia Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 46. Latin America Nucleic Acid Based Gene Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Latin America Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2017-2028)
Figure 48. Latin America Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2017-2028)
Figure 49. Latin America Nucleic Acid Based Gene Therapy Market Size Share by Country (2017-2028)
Figure 50. Mexico Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Brazil Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2017-2028)
Figure 54. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2017-2028)
Figure 55. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size Share by Country (2017-2028)
Figure 56. Turkey Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. UAE Nucleic Acid Based Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Wave Life Sciences Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2017-2022)
Figure 60. Imugene Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2017-2022)
Figure 61. Sarepta Therapeutics Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2017-2022)
Figure 62. Alnylam Pharmaceuticals Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2017-2022)
Figure 63. Ionis Pharmaceuticals Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2017-2022)
Figure 64. Moderna Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2017-2022)
Figure 65. BioNTech Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2017-2022)
Figure 66. Nutcracker Therapeutics Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2017-2022)
Figure 67. Deep Genomics Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2017-2022)
Figure 68. Sirnaomics Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2017-2022)
Figure 69. Laronde Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2017-2022)
Figure 70. Abogen Biosciences Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
細胞＆遺伝子治療用解凍装置のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Cell And Gene Therapy Thawing Equipment Market Due to the COVID-19 pandemic, the global Cell And Gene Therapy Thawing Equipment market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % d…- 細胞＆遺伝子治療製造サービスのグローバル市場インサイト・予測（～2028年） Gene therapy aims to treat disorders by replacing or introducing genes into cells— either inside the body (in vivo) or outside of the body (ex vivo). Market Analysis and Insights: Global Cell and Gene Therapy Manufacturing Services Market The global Cell and Gene Therapy Manufacturing Services marke…
- 世界の核酸検出装置市場予測（～2028年）：核酸抽出器、遠心分離機、その他 The Nucleic Acid Detection Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- クローニングサービスのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Cloning Service Market The global Cloning Service market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Standard Gene accounting for % of the …
- 核酸精製用キットのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Kits for Nucleic Acid Purification Market Due to the COVID-19 pandemic, the global Kits for Nucleic Acid Purification market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the …